Biosynthesis of Galactofuranose in Kinetoplastids: Novel Therapeutic Targets for Treating Leishmaniasis and Chagas' Disease

dc.contributor.authorOppenheimer, Michelleen
dc.contributor.authorValenciano Murillo, Ana L.en
dc.contributor.authorSobrado, Pabloen
dc.contributor.departmentBiochemistryen
dc.date.accessioned2017-09-18T09:52:03Zen
dc.date.available2017-09-18T09:52:03Zen
dc.date.issued2011-05-25en
dc.date.updated2017-09-18T09:52:02Zen
dc.description.abstractCell surface proteins of parasites play a role in pathogenesis by modulating mammalian cell recognition and cell adhesion during infection. β-Galactofuranose (Galf) is an important component of glycoproteins and glycolipids found on the cell surface of Leishmania spp. and Trypanosoma cruzi. β-Galf-containing glycans have been shown to be important in parasite-cell interaction and protection against oxidative stress. Here, we discuss the role of β-Galf in pathogenesis and recent studies on the Galf-biosynthetic enzymes: UDP-galactose 4′ epimerase (GalE), UDP-galactopyranose mutase (UGM), and UDP-galactofuranosyl transferase (GalfT). The central role in Galf formation, its unique chemical mechanism, and the absence of a homologous enzyme in humans identify UGM as the most attractive drug target in the β-Galf-biosynthetic pathway in protozoan parasites.en
dc.description.versionPublished versionen
dc.format.mimetypeapplication/pdfen
dc.identifier.citationMichelle Oppenheimer, Ana L. Valenciano, and Pablo Sobrado, “Biosynthesis of Galactofuranose in Kinetoplastids: Novel Therapeutic Targets for Treating Leishmaniasis and Chagas' Disease,” Enzyme Research, vol. 2011, Article ID 415976, 13 pages, 2011. doi:10.4061/2011/415976en
dc.identifier.doihttps://doi.org/10.4061/2011/415976en
dc.identifier.urihttp://hdl.handle.net/10919/79021en
dc.language.isoenen
dc.publisherHindawien
dc.rightsCreative Commons Attribution 4.0 Internationalen
dc.rights.holderCopyright © 2011 Michelle Oppenheimer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.en
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en
dc.titleBiosynthesis of Galactofuranose in Kinetoplastids: Novel Therapeutic Targets for Treating Leishmaniasis and Chagas' Diseaseen
dc.title.serialEnzyme Researchen
dc.typeArticle - Refereeden
dc.type.dcmitypeTexten

Files

Original bundle
Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
ER.2011.415976.pdf
Size:
941.75 KB
Format:
Adobe Portable Document Format
Description:
Published version
Name:
ER.2011.415976.xml
Size:
6.64 KB
Format:
Extensible Markup Language
License bundle
Now showing 1 - 1 of 1
Name:
license.txt
Size:
1.5 KB
Format:
Item-specific license agreed upon to submission
Description: